TrialBritish journal of clinical pharmacology2017

Assessment of pharmacokinetic interaction between rilotumumab and epirubicin, cisplatin and capecitabine (ECX) in a Phase 3 study in gastric cancer.

Yilong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.